N. Parameswaran

发表

Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment.

J. Langston, R. Tyndale, M. Quik, 2006, Journal of neurochemistry.

Differential Regulation of Mesolimbic α3*/α6β2* and α4β2* Nicotinic Acetylcholine Receptor Sites and Function after Long-Term Oral Nicotine to Monkeys

M. Quik, S. McCallum, N. Parameswaran, 2006, Journal of Pharmacology and Experimental Therapeutics.

Differential regulation of mesolimbic alpha 3/alpha 6 beta 2 and alpha 4 beta 2 nicotinic acetylcholine receptor sites and function after long-term oral nicotine to monkeys.

M. Quik, S. McCallum, N. Parameswaran, 2006, The Journal of pharmacology and experimental therapeutics.

Multiple roles for nicotine in Parkinson's disease.

M. Quik, N. Parameswaran, T. Bordia, 2009, Biochemical pharmacology.

Chronic Nicotine Treatment Increases nAChRs and Microglial Expression in Monkey Substantia Nigra After Nigrostriatal Damage

J. Langston, M. Quik, N. Parameswaran, 2009, Journal of Molecular Neuroscience.

Decrease in (cid:1) 3*/ (cid:1) 6* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage

S. Grady, M. Quik, S. McCallum, 2005 .

Cotinine Selectively Activates a Subpopulation of (cid:1) 3/ (cid:1) 6 (cid:2) 2* Nicotinic Receptors in Monkey Striatum

M. Quik, N. Parameswaran, J. McIntosh, 2008 .

Partial Recovery of Striatal Nicotinic Receptors in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Monkeys with Chronic Oral Nicotine

J. Langston, M. Quik, N. Parameswaran, 2006, Journal of Pharmacology and Experimental Therapeutics.

Long-Term Nicotine Treatment Decreases Striatal α6* Nicotinic Acetylcholine Receptor Sites and Function in Mice

J. Lindstrom, S. Grady, M. Quik, 2005, Molecular Pharmacology.

Guidelines on nicotine dose selection for in vivo research

A. C. Collins, E. Levin, W. Schafer, 2007, Psychopharmacology.

Cotinine Selectively Activates a Subpopulation of α3/α6β2* Nicotinic Receptors in Monkey Striatum

M. Quik, N. Parameswaran, J. McIntosh, 2008, Journal of Pharmacology and Experimental Therapeutics.

Chronic oral nicotine treatment protects against striatal degeneration in MPTP‐treated primates

J. Langston, R. Tyndale, D. D. Di Monte, 2006, Journal of neurochemistry.

Nicotine reduces levodopa‐induced dyskinesias in lesioned monkeys

D. D. Di Monte, M. Quik, N. Parameswaran, 2007, Annals of neurology.

Chronic Oral Nicotine Normalizes Dopaminergic Function and Synaptic Plasticity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Primates

J. Langston, Li Chen, M. Quik, 2006, The Journal of Neuroscience.

Increases in α4* but not α3*/α6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment

R. Tyndale, M. Quik, S. McCallum, 2006 .

Decrease in α3*/α6* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage

S. Grady, M. Quik, S. McCallum, 2005, Molecular Pharmacology.

Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys

M. Quik, N. Parameswaran, T. Bordia, 2009, Journal of neurochemistry.

Pre‐synaptic dopaminergic compensation after moderate nigrostriatal damage in non‐human primates

M. Quik, N. Parameswaran, Luping Z. Huang, 2008, Journal of neurochemistry.

Compensation in pre‐synaptic dopaminergic function following nigrostriatal damage in primates

S. Grady, M. Quik, S. McCallum, 2006, Journal of neurochemistry.

Paraquat Exposure Reduces Nicotinic Receptor-Evoked Dopamine Release in Monkey Striatum

D. D. Di Monte, M. Quik, N. Parameswaran, 2008, Journal of Pharmacology and Experimental Therapeutics.

Prominent Role of α3/α6β2* nAChRs in Regulating Evoked Dopamine Release in Primate Putamen: Effect of Long-Term Nicotine Treatment

M. Quik, N. Parameswaran, J. McIntosh, 2009, Molecular Pharmacology.

Multiple roles for nicotine in Parkinson's disease.

M. Quik, N. Parameswaran, T. Bordia, 2009, Biochemical pharmacology.

Chronic nicotine treatment decreases striatal α 6* nAChR sites and function in mice

S. Grady, N. Parameswaran, J. McIntosh, 2005 .